RSS
Joseph Jimenez
CEO, Divisional
Novartis AG ADS
Basel
,
SZ
Sector: HEALTHCARE / Drug Manufacturers - Major
Officer since April 2007
49 Years Old
Joseph Jimenez graduated with a B.A. degree from Stanford University in 1982 and earned an M.B.A. from the University of California, Berkley in 1984. He began his career at The Clorox Company, California, and later served as president of two operating divisions at ConAgra, Nebraska. In 1998, he joined the H.J. Heinz Company, Pennsylvania, and was named President and Chief Executive Officer of the North America business. From 2002 to 2006 he served as President and Chief Executive Officer of Heinz in Europe. Before joining Novartis, he served as a non-executive director of AstraZeneca plc, United Kingdom, from 2002 to 2007, and was an advisor for the private equity organization Blackstone Group, New York. He joined Novartis in April 2007 as CEO of the Consumer Health Division. He was appointed to his present position as CEO of the Pharmaceuticals Division in October 2007.
Compensation for 2008
| Salary | CHF941,670.00 |
| Bonus | CHF1,197,000.00 |
| Other Annual Compensation | CHF0.00 |
| Long term incentive plan payouts | CHF0.00 |
| Restricted stock awards | CHF0.00 |
| Security underlying options | CHF0.00 |
| All other compensation | CHF202,152.00 |
| Option awards $ | CHF0.00 |
| Non-equity incentive plan compensation | CHF0.00 |
| Change in pension value and nonqualified deferred compensation earnings | CHF227,009.00 |
| Total Compensation | CHF2,567,831.00 |
Director Compensation (AstraZeneca PLC)
for 2007
| Fees earned or paid in cash | $28,000.00 |
| Stock awards | $0.00 |
| Option awards (in $) | $0.00 |
| Non-equity incentive plan compensation | $0.00 |
| Change in pension value and nondisqualified compensation earnings | $0.00 |
| All other compensation | $0.00 |
| Total Compensation | $28,000.00 |
Director Compensation (AstraZeneca PLC)
for 2006
| Fees earned or paid in cash | $89,000.00 |
| Stock awards | $0.00 |
| Option awards (in $) | $0.00 |
| Non-equity incentive plan compensation | $0.00 |
| Change in pension value and nondisqualified compensation earnings | $0.00 |
| All other compensation | $0.00 |
| Total Compensation | $89,000.00 |
Director Compensation (AstraZeneca PLC)
for 2005
| Fees earned or paid in cash | $90,000.00 |
| Stock awards | $0.00 |
| Option awards (in $) | $0.00 |
| Non-equity incentive plan compensation | $0.00 |
| Change in pension value and nondisqualified compensation earnings | $0.00 |
| All other compensation | $0.00 |
| Total Compensation | $90,000.00 |
Director Compensation (Blue Nile Inc)
for 2007
| Fees earned or paid in cash | $33,000.00 |
| Stock awards | $0.00 |
| Option awards (in $) | $30,262.00 |
| Non-equity incentive plan compensation | $0.00 |
| Change in pension value and nondisqualified compensation earnings | $0.00 |
| All other compensation | $0.00 |
| Total Compensation | $63,262.00 |
Director Compensation (Blue Nile Inc)
for 2006
| Fees earned or paid in cash | $2,567.00 |
| Stock awards | $19,933.00 |
| Option awards (in $) | $65,344.00 |
| Non-equity incentive plan compensation | $0.00 |
| Change in pension value and nondisqualified compensation earnings | $0.00 |
| All other compensation | $0.00 |
| Total Compensation | $87,844.00 |
RSS Feed on Joseph JimenezForbes.com Headlines
Shareholders have waited all too long for William Johnson to fix Heinz. He promises one saucy turnaround.
